Skip to main content
Top
Published in: Journal of Nuclear Cardiology 6/2009

01-12-2009 | Original Article

Does myocardial perfusion scintigraphy predict improvement in symptoms and exercise capacity following successful elective percutaneous coronary intervention?

Authors: M. Bashar Al-Housni, MRCP, Fiona Hutchings, Miles Dalby, MD, MRCP, Michael Dubowitz, DPhil, MRCP, Richard Grocott-Mason, MD, MRCP, Charles D. J. Ilsley, FRCP, Mark Mason, MRCP, Andrew G. Mitchell, FRCP, Andrew D. Kelion, DM, MRCP

Published in: Journal of Nuclear Cardiology | Issue 6/2009

Login to get access

Abstract

Background

Elective percutaneous coronary intervention (PCI) without inducible ischaemia may not be beneficial. We investigated the prevalence of inducible hypoperfusion using myocardial perfusion scintigraphy (MPS) in patients undergoing PCI, and its ability to predict functional outcome.

Methods and Results

One hundred and twenty-three patients listed for elective PCI underwent MPS, using treadmill exercise where possible. Seventy-seven patients (63%) described chest pain in daily life. Seventy-four of 103 (72%) exercise ECG tests were positive. Ninety-one (74%) had inducible hypoperfusion on MPS (extensive in 25; 20%). Interventionalists were blinded to the scintigraphic results, and PCI was performed as planned. Six months later, Seattle Angina Questionnaire physical limitation score had improved from 66 to 76 (P < 0.0001), and peak treadmill workload from 7.2 ± 2.3 to 9.0 ± 2.7 METS (P < 0.0001). Sex, limiting chest pain on baseline exercise testing, and MPS summed difference score (SDS) were independent predictors of improvement. Patients with both limiting chest pain and SDS ≥ 7 demonstrated an increase of 3.3 ± 1.8 METS, compared with ≈1.5 METS for other subgroups (P < 0.05).

Conclusions

Many patients undergoing elective PCI in a UK centre have little or no evidence of inducible hypoperfusion. The combination of limiting chest pain during exercise testing and significant inducible hypoperfusion on MPS predicts a large increase in exercise capacity after PCI.
Literature
2.
go back to reference Department of Health. National Service Framework for coronary heart disease. London: Department of Health; 2000. Department of Health. National Service Framework for coronary heart disease. London: Department of Health; 2000.
3.
go back to reference Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Eng J Med 2007;356:1503-16.CrossRef Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Eng J Med 2007;356:1503-16.CrossRef
4.
go back to reference Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: The evidence. Eur J Nucl Med Mol Imaging 2004;31:261-91.CrossRefPubMed Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: The evidence. Eur J Nucl Med Mol Imaging 2004;31:261-91.CrossRefPubMed
5.
go back to reference Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-70.PubMed Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-70.PubMed
6.
go back to reference Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-6.CrossRefPubMed Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-6.CrossRefPubMed
7.
go back to reference Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:216-35.CrossRefPubMed Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:216-35.CrossRefPubMed
8.
go back to reference Rahman SL, Kelion AD. Nuclear Cardiology in the UK: Do we apply evidence-based medicine? Heart 2004;90(Suppl 5):v37-40.CrossRefPubMed Rahman SL, Kelion AD. Nuclear Cardiology in the UK: Do we apply evidence-based medicine? Heart 2004;90(Suppl 5):v37-40.CrossRefPubMed
9.
go back to reference Spertus JA, Winder JA, Dewhurst TA, Fihn SD. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-41.CrossRefPubMed Spertus JA, Winder JA, Dewhurst TA, Fihn SD. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-41.CrossRefPubMed
10.
go back to reference Pereztol-Valdés O, Candell-Riera J, Santana-Boado C, Angel J, Aguadé-Bruix S, Castell-Conesa J, et al. Correspondence between left ventricular 17 myocardial segments and coronary arteries. Eur Heart J 2005;26:2637-43.CrossRefPubMed Pereztol-Valdés O, Candell-Riera J, Santana-Boado C, Angel J, Aguadé-Bruix S, Castell-Conesa J, et al. Correspondence between left ventricular 17 myocardial segments and coronary arteries. Eur Heart J 2005;26:2637-43.CrossRefPubMed
11.
go back to reference Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol 1983;1:574-5.PubMedCrossRef Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol 1983;1:574-5.PubMedCrossRef
12.
go back to reference Wong Y, Rodwell A, Dawkins S, Livesey SA, Simpson IA. Sex differences in investigation results and treatment in subjects referred for investigation of chest pain. Heart 2001;85:149-52.CrossRefPubMed Wong Y, Rodwell A, Dawkins S, Livesey SA, Simpson IA. Sex differences in investigation results and treatment in subjects referred for investigation of chest pain. Heart 2001;85:149-52.CrossRefPubMed
13.
go back to reference Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 2008;300:1765-73.CrossRefPubMed Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 2008;300:1765-73.CrossRefPubMed
14.
go back to reference Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy. Circulation 2008;117:1283-91.CrossRefPubMed Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy. Circulation 2008;117:1283-91.CrossRefPubMed
15.
go back to reference Christou MA, Siontis GC, Katritsis DG, Ioannidis JP. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol 2007;99:450-6.CrossRefPubMed Christou MA, Siontis GC, Katritsis DG, Ioannidis JP. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol 2007;99:450-6.CrossRefPubMed
16.
go back to reference Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis. Comparison with 201Tl and regional myocardial blood flow. Circulation 1997;96:2332-8.PubMed Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis. Comparison with 201Tl and regional myocardial blood flow. Circulation 1997;96:2332-8.PubMed
17.
go back to reference Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, et al. The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003;107:1359-65.CrossRefPubMed Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, et al. The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003;107:1359-65.CrossRefPubMed
18.
go back to reference Azarbal B, Hayes SW, Lewin HC, Hachamovitch R, Cohen I, Berman DS. The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion single-photon emission computed tomography in the prediction of cardiac death and all-cause mortality: Superiority over 85% of maximal age-predicted heart rate. J Am Coll Cardiol 2004;44:423-30.CrossRefPubMed Azarbal B, Hayes SW, Lewin HC, Hachamovitch R, Cohen I, Berman DS. The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion single-photon emission computed tomography in the prediction of cardiac death and all-cause mortality: Superiority over 85% of maximal age-predicted heart rate. J Am Coll Cardiol 2004;44:423-30.CrossRefPubMed
19.
go back to reference Johansen A, Høilund-Carlsen PF, Christensen HW, Vach W, Møldrup M, Haghfelt T. Use of myocardial perfusion imaging to predict the effectiveness of coronary revascularisation in patients with stable angina pectoris. Eur J Nucl Med Mol Imaging 2005;32:1363-70.CrossRefPubMed Johansen A, Høilund-Carlsen PF, Christensen HW, Vach W, Møldrup M, Haghfelt T. Use of myocardial perfusion imaging to predict the effectiveness of coronary revascularisation in patients with stable angina pectoris. Eur J Nucl Med Mol Imaging 2005;32:1363-70.CrossRefPubMed
20.
go back to reference Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.CrossRefPubMed Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.CrossRefPubMed
Metadata
Title
Does myocardial perfusion scintigraphy predict improvement in symptoms and exercise capacity following successful elective percutaneous coronary intervention?
Authors
M. Bashar Al-Housni, MRCP
Fiona Hutchings
Miles Dalby, MD, MRCP
Michael Dubowitz, DPhil, MRCP
Richard Grocott-Mason, MD, MRCP
Charles D. J. Ilsley, FRCP
Mark Mason, MRCP
Andrew G. Mitchell, FRCP
Andrew D. Kelion, DM, MRCP
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 6/2009
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-009-9112-y

Other articles of this Issue 6/2009

Journal of Nuclear Cardiology 6/2009 Go to the issue